Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
32.32 INR | -1.97% | +1.22% | +50.47% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 220.5 | 142.5 | 117.4 | 309.5 | 163.8 | 144.9 |
Enterprise Value (EV) 1 | 289.7 | 183.2 | 162.2 | 354.7 | 212.8 | 188.1 |
P/E ratio | 851 x | -36.5 x | -83.9 x | -12 x | -37.2 x | 7.19 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 7.28 x | - | - | - | - | - |
EV / Revenue | 9.56 x | - | - | - | - | - |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | 3.3 x | 67.6 x | -40.7 x | 25.1 x | -98.6 x | -10 x |
FCF Yield | 30.3% | 1.48% | -2.46% | 3.98% | -1.01% | -9.96% |
Price to Book | -7.91 x | -4.49 x | -3.55 x | -5.26 x | -2.59 x | -3.37 x |
Nbr of stocks (in thousands) | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 |
Reference price 2 | 22.05 | 14.25 | 11.74 | 30.95 | 16.38 | 14.49 |
Announcement Date | 27/09/18 | 29/08/19 | 04/09/20 | 27/08/21 | 01/09/22 | 25/07/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 30.31 | - | - | - | - | - |
EBITDA | - | - | - | - | - | - |
EBIT 1 | 2.766 | -2.645 | -1.378 | -1.573 | -4.377 | -6.18 |
Operating Margin | 9.13% | - | - | - | - | - |
Earnings before Tax (EBT) 1 | 0.433 | -4.165 | -1.355 | -27.47 | -4.377 | 20.63 |
Net income 1 | 0.259 | -3.888 | -1.355 | -25.73 | -4.366 | 20.16 |
Net margin | 0.85% | - | - | - | - | - |
EPS 2 | 0.0259 | -0.3900 | -0.1400 | -2.573 | -0.4400 | 2.016 |
Free Cash Flow 1 | 87.73 | 2.711 | -3.989 | 14.12 | -2.158 | -18.73 |
FCF margin | 289.48% | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | 33,872.44% | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 27/09/18 | 29/08/19 | 04/09/20 | 27/08/21 | 01/09/22 | 25/07/23 |
Balance Sheet Analysis
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 69.2 | 40.7 | 44.8 | 45.2 | 49 | 43.2 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 87.7 | 2.71 | -3.99 | 14.1 | -2.16 | -18.7 |
ROE (net income / shareholders' equity) | -0.93% | 13% | 4.18% | 56% | 7.16% | -38% |
ROA (Net income/ Total Assets) | 0.95% | -3.96% | -7.12% | -14.1% | -141% | -260% |
Assets 1 | 27.17 | 98.2 | 19.03 | 183 | 3.103 | -7.745 |
Book Value Per Share 2 | -2.790 | -3.180 | -3.310 | -5.880 | -6.320 | -4.300 |
Cash Flow per Share 2 | 0.4600 | 0.0100 | 0.0100 | 0.0500 | 0.0300 | 0 |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 27/09/18 | 29/08/19 | 04/09/20 | 27/08/21 | 01/09/22 | 25/07/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+50.47% | 3.95M | |
-7.08% | 26.09B | |
+1.60% | 20.05B | |
-19.30% | 9.59B | |
+1.18% | 9.09B | |
-3.34% | 6.8B | |
-9.91% | 5.53B | |
+48.05% | 5B | |
-5.74% | 2.33B | |
-14.51% | 2.06B |
- Stock Market
- Equities
- ROSELABS6 Stock
- Financials Roselabs Finance Limited